Table V.
Impact of ERAS protocols for oncological surgery of the head and neck on length of stay.
| Study | Number of patients | Length of stay (days) | ||||
|---|---|---|---|---|---|---|
| Name | Study type | ERAS | Control group | ERAS | Control group | P-value |
| Current study | Prospective | 40 | 40 (matched) | 14 (10-19.5)* | 17.50 (13-21)* | 0.013 |
| Bater 2017 2 | Prospective | 100 | 40 | 10 (8-14)* | 14.00 (11-21)* | 0.003 |
| Jandali 2019 4 | Retrospective | 92 | 93 | 7.8 ± 4.8** | 9.7 ± 4.7** | 0.008 |
| Coyle 2016 5 | Prospective | 31 | - | 14.55 ± 7.48** | 18** | - |
| Bertelsen 2020 22 | Prospective | 61 | 61 | 10 | 8.5 | 0.346 |
| Kiong 2021 1 | Retrospective | 200 | 200 (matched) | 7.2 ± 2.3** | 8.7 ± 4.2** | < 0.001 |
* median (first quartile-third quartile)
** mean ± standard deviation.